• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性:经济负担与基于价值的医学分析

Age-related macular degeneration: economic burden and value-based medicine analysis.

作者信息

Brown Melissa M, Brown Gary C, Stein Joshua D, Roth Zachary, Campanella Joseph, Beauchamp George R

机构信息

Center for Value-Based Medicine, Flourtown 19031, and the Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, USA.

出版信息

Can J Ophthalmol. 2005 Jun;40(3):277-87. doi: 10.1016/S0008-4182(05)80070-5.

DOI:10.1016/S0008-4182(05)80070-5
PMID:15947797
Abstract

It can be estimated that 17,100 new cases of neovascular (wet) AMD and 180,000 new cases of geographic-atrophy (dry) AMD occur in Canada annually. In addition to having a devastating effect on patients' lives, the condition causes significant adverse consequences for the economy. The deleterious effect of AMD on quality of life is markedly underestimated by ophthalmologists who treat patients with AMD, by non-ophthalmic physicians and by the public. In fact, patients with different degrees of severity of AMD have a perceived impairment of their quality of life that is 96% to 750% greater than the impairment estimated by treating ophthalmologists. Mild AMD causes a 17% decrease in the quality of life of the average patient, a decrease similar to that encountered with symptomatic human immunodeficiency virus infection or moderate cardiac angina. Moderate AMD produces a 40% decrease in quality of life, a decrease similar to that associated with permanent renal dialysis or severe cardiac angina. Very severe AMD causes a 63% decrement in quality of life, a decrease similar to that encountered with advanced prostatic cancer with uncontrollable pain or a severe stroke that leaves a person bedridden, incontinent and requiring constant nursing care. The adverse economic consequences of AMD include an annual $2.6 billion negative impact on Canada's gross domestic product. The return on investment is high for both current AMD therapies and research into new treatment modalities.

摘要

据估计,加拿大每年有17100例新生血管性(湿性)年龄相关性黄斑变性(AMD)病例和180000例地图状萎缩性(干性)AMD病例。除了对患者的生活造成毁灭性影响外,这种疾病还会给经济带来重大不利后果。AMD对生活质量的有害影响被治疗AMD患者的眼科医生、非眼科医生和公众严重低估。事实上,不同严重程度的AMD患者所感受到的生活质量受损程度比治疗眼科医生估计的受损程度高96%至750%。轻度AMD会使普通患者的生活质量下降17%,这一下降幅度与有症状的人类免疫缺陷病毒感染或中度心绞痛患者相似。中度AMD会使生活质量下降40%,这一下降幅度与永久性肾透析或严重心绞痛患者相似。非常严重的AMD会使生活质量下降63%,这一下降幅度与伴有无法控制疼痛的晚期前列腺癌患者或导致患者卧床不起、大小便失禁且需要持续护理的严重中风患者相似。AMD的不良经济后果包括每年给加拿大国内生产总值带来26亿美元的负面影响。对于当前的AMD治疗方法和新治疗方式的研究,投资回报率都很高。

相似文献

1
Age-related macular degeneration: economic burden and value-based medicine analysis.年龄相关性黄斑变性:经济负担与基于价值的医学分析
Can J Ophthalmol. 2005 Jun;40(3):277-87. doi: 10.1016/S0008-4182(05)80070-5.
2
The burden of age-related macular degeneration: a value-based medicine analysis.年龄相关性黄斑变性的负担:基于价值医疗的分析
Trans Am Ophthalmol Soc. 2005;103:173-84; discussion 184-6.
3
The burden of age-related macular degeneration: a value-based analysis.年龄相关性黄斑变性的负担:基于价值的分析。
Curr Opin Ophthalmol. 2006 Jun;17(3):257-66. doi: 10.1097/01.icu.0000193079.55240.18.
4
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.双侧新生血管性年龄相关性黄斑变性的经济负担:多国观察性研究。
Pharmacoeconomics. 2008;26(1):57-73. doi: 10.2165/00019053-200826010-00006.
5
Burden of illness of neovascular age-related macular degeneration in Canada.加拿大新生血管性年龄相关性黄斑变性的疾病负担。
Can J Ophthalmol. 2007 Dec;42(6):836-43. doi: 10.3129/i07-153.
6
Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.1995年至1999年年龄相关性黄斑变性患者的眼部相关医疗保险费用。
Ophthalmology. 2008 Jan;115(1):18-25. doi: 10.1016/j.ophtha.2007.04.016. Epub 2007 Jun 18.
7
[Age-related macular degeneration: a socioeconomic time bomb in our aging society].[年龄相关性黄斑变性:我们老龄化社会中的一颗社会经济定时炸弹]
Ophthalmologe. 2006 Sep;103(9):742-8. doi: 10.1007/s00347-006-1418-4.
8
The treatment of wet AMD in Canada: access to therapy (policy review).加拿大湿性年龄相关性黄斑变性的治疗:治疗可及性(政策审查)
Can J Ophthalmol. 2009 Oct;44(5):548-56. doi: 10.3129/i09-140.
9
[Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications].[德国的新生血管性年龄相关性黄斑变性。对生活质量的影响及经济负担]
Ophthalmologe. 2009 Mar;106(3):242-51. doi: 10.1007/s00347-008-1797-9.
10
Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.糖尿病视网膜病变筛查中筛查中老年相关黄斑变性的成本效益。
Ophthalmology. 2015 Nov;122(11):2278-85. doi: 10.1016/j.ophtha.2015.06.050. Epub 2015 Aug 24.

引用本文的文献

1
Impact of the COVID-19 pandemic on the Andalusian program for early detection of diabetic retinopathy: a population-based study.2019年冠状病毒病大流行对安达卢西亚糖尿病视网膜病变早期检测项目的影响:一项基于人群的研究。
Front Clin Diabetes Healthc. 2025 Aug 14;6:1631252. doi: 10.3389/fcdhc.2025.1631252. eCollection 2025.
2
Cost-Effectiveness of Alternative Treatment Strategies of Subretinal Macular Hemorrhage.视网膜下黄斑出血替代治疗策略的成本效益
Healthcare (Basel). 2025 Jun 29;13(13):1550. doi: 10.3390/healthcare13131550.
3
A scoping review of artificial intelligence as a medical device for ophthalmic image analysis in Europe, Australia and America.
欧洲、澳大利亚和美洲将人工智能作为眼科图像分析医疗设备的范围综述。
NPJ Digit Med. 2025 May 29;8(1):323. doi: 10.1038/s41746-025-01726-8.
4
Retinal Thickness Analysis Using Optical Coherence Tomography: Diagnostic and Monitoring Applications in Retinal Diseases.使用光学相干断层扫描的视网膜厚度分析:在视网膜疾病中的诊断与监测应用
Diagnostics (Basel). 2025 Mar 25;15(7):833. doi: 10.3390/diagnostics15070833.
5
Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US.保加利亚、德国和美国晚期年龄相关性黄斑变性的经济负担
JAMA Ophthalmol. 2024 Dec 1;142(12):1123-1130. doi: 10.1001/jamaophthalmol.2024.4401.
6
The Effects of STRA6 Regulation of the Circadian Rhythm on Choroidal Neovascularization.STRA6 调控生物钟节律对脉络膜新生血管的影响。
Invest Ophthalmol Vis Sci. 2024 Sep 3;65(11):21. doi: 10.1167/iovs.65.11.21.
7
RPE Curvature Can Screen for Early and Intermediate AMD.RPE 曲线可筛查早中期 AMD。
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):2. doi: 10.1167/iovs.65.2.2.
8
Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration.治疗抵抗性新生血管性年龄相关性黄斑变性患者换用阿柏西普或雷珠单抗后对治疗的依从性。
Indian J Ophthalmol. 2024 Jan 1;72(Suppl 1):S101-S105. doi: 10.4103/IJO.IJO_1795_23. Epub 2023 Dec 22.
9
Screening for biomarkers in age-related macular degeneration.年龄相关性黄斑变性生物标志物的筛查
Heliyon. 2023 Jun 17;9(7):e16981. doi: 10.1016/j.heliyon.2023.e16981. eCollection 2023 Jul.
10
Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness.年龄相关性黄斑变性:一种视觉障碍和不可逆失明的指数级增长的迫在眉睫的威胁。
Cureus. 2023 May 29;15(5):e39624. doi: 10.7759/cureus.39624. eCollection 2023 May.